The 2018 American College of Rheumatology and the National Psoriasis Foundation released updated treatment guidelines for psoriatic arthritis (PsA). Test your knowledge of the current therapeutic recommendations for PsA in this quiz.
In patients with psoriatic arthritis (PsA) who are treatment naïve to oral small molecules (OSMs), methotrexate (MTX), interleukins (IL) biologics, tumor necrosis factor inhibitor (TNFi) biologics or other agents, which of the following therapies is preferable to OSMs?
a. IL-17 biologics
c. TNFi biologics
d. none of the above
2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.